Research  |  Core Facilities  |  Patient Studies  |  Tech Transfer  |  Seminars  |  Intranet  |  Jobs  |  Search  |  Contact Us  |  Ways To Give                             HOME  
 

 

More about
Dr. James:

Dr. James' profile

Dr. James 101
(for non-scientists)

Dr. James' CV in brief

Publications

COBRE on Science in a Culture of Mentoring

Clinical Immunology Research Program

Dr. James In The News

OMRF chosen as one of nine Autoimmunity Centers of Excellence nationwide

OMRF adds new patient-oriented Clinical Immunology Research Program

 

 

Judith A. James, M.D., Ph.D.
Member, Clinical Immunology Research Program
Lou C. Kerr Chair in Biomedical Research
Professor, Department of Medicine, University of Oklahoma Health Sciences
  Center
Adjunct Professor, Department of Pathology, University of Oklahoma Health
  Sciences Center


Recent Publications
Namjou B, Gray-McGuire C, Sestak AL, Gilkeson GS, Jacob CO, Merrill JT, James JA, Wakeland EK, Li QZ, Langefeld CD, Divers J, Ziegler J, Moser KL, Kelly JA, Kaufman KM, Harley JB.   Evaluation of C1q genomic region in minority racial groups of lupus. Genes Immun 2009. [Abstract] EPub

Bates JS, Lessard CJ, Leon JM, Nguyen T, Battiest LJ, Rodgers J, Kaufman KM, James JA, Gilkeson GS, Kelly JA, Humphrey MB, Harley JB, Gray-McGuire C, Moser KL, Gaffney PM. Meta-analysis and imputation identifies a 109 kb risk haplotype spanning TNFAIP3 associated with lupus nephritis and hematologic manifestations. Genes Immun 2009. [Abstract] EPub

Douglas KB, Windels DC, Zhao J, Gadeliya AV, Wu H, Kaufman KM, Harley JB, Merrill J, Kimberly RP, Alarcon GS, Brown EE, Edberg JC, Ramsey-Goldman R, Petri M, Reveille JD, Vila LM, Gaffney PM, James JA, Moser KL, Alarcon-Riquelme ME, Vyse TJ, Gilkeson GS, Jacob CO, Ziegler JT, Langefeld CD, Ulgiati D, Tsao BP, Boackle SA. Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing. Genes Immun 2009. [Abstract] EPub

Selected Publications
Sestak AL, Nath SK, Kelly JA, Bruner GR, James JA, Harley JB. Patients with familial and sporadic onset SLE have similar clinical profiles but vary profoundly by race. Lupus Nov; 17(11):1004-9, 2008 [Abstract]

Wrammert J, Smith K, Miller J, Langley WA, Kokko K, Larsen C, Zheng NY, Mays I, Garman L, Helms C, James J, Air GM, Capra JD, Ahmed R, Wilson PC. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453:667-71, 2008. [Abstract]

Cooper GS, Gilbert KM, Greidinger EL, James JA, Pfau JC, Reinlib L, Richardson BC, Rose NR. Recent advances and opportunities in research on lupus: environmental influences and mechanisms of disease. Environ Health Perspect 116:695-702, 2008. [Abstract]

Han S, Guthridge JM, Harley IT, Sestak AL, Kim-Howard X, Kaufman KM, Namjou B, Deshmukh H, Bruner G, Espinoza LR, Gilkeson GS, Harley JB, James JA, Nath SK. Osteopontin and systemic lupus erythematosus association: a probable gene-gender interaction. PLoS ONE 3:e0001757, 2008. [Abstract]

James J, Kim-Howard X, Bruner B, Jonsson M, McClain M, Arbuckle M, Walker C, Dennis G, Merrill J, Harley J. Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus. Lupus 16:401-409, 2007. [Abstract]

Heinlen LD, McClain MT, Merrill J, Akbarali YW, Edgerton CC, Harley JB, James JA. Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms. Arthritis Rheum 56:2344-2351, 2007. [Abstract]

 

Email This PageEmail this page